MedTrace Logo

Termination of Early Pregnancy in Scarred Uterus With Lletrozole and Misoprostol Compared to Misoprostol Alone

NCT05067309 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2021-10-05

No results posted yet for this study

Summary

Termination of early pregnancy in scarred uterus with letrozole and misoprostol compared to Misoprostol alone

Conditions

  • Termination of Early Pregnancy in Scarred Uterus

Interventions

DRUG

Letrozole 2.5mg

Missed abortion received letrozole then misoprostol

Sponsors & Collaborators

  • Ahmed Elsayed Aref

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-04-01
Completion
2022-08-01
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05067309 on ClinicalTrials.gov